Clinical Trials Directory

Trials / Completed

CompletedNCT00808197

Choroidal Blood Flow and Progression of Age-Related Macular Degeneration in the Fellow Eye in Patients With Unilateral Choroidal Neovascularisation

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
41 (estimated)
Sponsor
Medical University of Vienna · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

Age-related macular degeneration (AMD) is the chief cause of severe and irreversible loss of vision in developed countries. The prevalence of AMD increases dramatically with age. The early stage (or dry AMD) is associated with minimal visual impairment and is characterized by large drusen and pigmentary abnormalities in the macula. The late stage is a neovascular, exudative form. This so called exudative AMD includes serous or hemorrhagic detachment of retinal pigment epithelium and choroidal neovascularization leading to severe loss of vision (20/200 or worse). Patients with unilateral CNV (choroidal neovascularisation) have a significant risk of CNV developing in the second eye. Choroidal blood flow is of great importance for normal visual function. Several reports have provided evidence suggesting that choroidal blood flow is decreased in subjects with AMD. In late stages of AMD angiogenesis leads to the formation of choroidal neovascularization that can cause severe visual impairment by disrupting normal macular function. The purpose of this evaluation is to investigate a possible link between alterations in choroidal blood flow and the development of CNV and serous detachment in the fellow eye of patients with AMD and unilateral neovascular maculopathy. This longitudinal study may provide important findings with respect to natural history and visual prognosis of patients with neovascularized AMD. Ocular blood flow will be determined by non-invasive methods, including laser Doppler flowmetry and laser interferometry

Conditions

Interventions

TypeNameDescription
PROCEDUREocular blood flow measurementOcular blood flow will be determined by non-invasive methods, including laser Doppler flowmetry and laser interferometry

Timeline

First posted
2008-12-15
Last updated
2008-12-15

Locations

1 site across 1 country: Austria

Source: ClinicalTrials.gov record NCT00808197. Inclusion in this directory is not an endorsement.